Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report)’s stock price dropped 5.8% on Monday . The company traded as low as $4.34 and last traded at $4.34. Approximately 170 shares were traded during mid-day trading, a decline of 93% from the average daily volume of 2,615 shares. The stock had previously closed at $4.60.
Mayne Pharma Group Price Performance
The stock’s 50 day moving average price is $3.34 and its two-hundred day moving average price is $3.07.
Mayne Pharma Group Company Profile
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division.
Read More
- Five stocks we like better than Mayne Pharma Group
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Comparing and Trading High PE Ratio Stocks
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
